Waters Corporation

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 10:44:45 2024-04-23 am EDT 5-day change 1st Jan Change
311.3 USD +4.04% Intraday chart for Waters Corporation -1.34% -5.99%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bernstein Adjusts Price Target on Waters to $304 From $307 MT
Baird Adjusts Price Target on Waters to $319 From $315 MT
Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns CI
Leerink Partners Adjusts Waters' Price Target to $338 From $335 MT
Transcript : Waters Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 11:10 AM
Barclays Adjusts Waters Price Target to $300 From $275, Maintains Underweight Rating MT
UBS Adjusts Price Target on Waters to $345 From $285, Maintains Neutral Rating MT
Transcript : Waters Corporation, Q4 2023 Earnings Call, Feb 06, 2024
Waters' Q4 Adjusted Earnings, Net Sales Decline MT
Earnings Flash (WAT) WATERS CORPORATION Posts Q4 Revenue $819.5M MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q4 EPS $3.62 MT
Waters Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Waters Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024 CI
BofA Securities Raises Price Target on Waters to $328 From $300, Maintains Neutral Rating MT
Barclays Adjusts Price Target on Waters to $275 From $230, Keeps Underweight Rating MT
Waters Corporation's Equity Buyback announced on January 23, 2019, has expired. CI
Transcript : Waters Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04:30 PM
Slow start for Wall Street Our Logo
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom... Our Logo
BofA Securities Adjusts Price Target on Waters to $300 From $265, Maintains Neutral Rating MT
Powell is getting ready to crush investors 'hopes Our Logo
Citigroup Adjusts Price Target on Waters to $300 From $265, Keeps Neutral Rating MT
ANALYST RECOMMENDATIONS : Adobe, AMD, Apple, Costco, HP, Snap... Our Logo
Transcript : Waters Corporation Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-30-2023 08:20 AM
Chart Waters Corporation
More charts
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
299.2 USD
Average target price
325.1 USD
Spread / Average Target
+8.65%
Consensus
  1. Stock Market
  2. Equities
  3. WAT Stock
  4. News Waters Corporation
  5. Waters : Posts Higher Q2 Earnings, Net Sales